Pfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study Finds

Singapore News News

Pfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study Finds
Singapore Latest News,Singapore Headlines
  • 📰 Forbes
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 53%

Two doses of Pfizer’s Covid-19 vaccine seem to provide just 33% protection against infection with the omicron coronavirus variant, however it does largely prevent severe disease

This protection is maintained across all age groups and for people with conditions including diabetes and high blood pressure, the data suggests, though there are slightly lower levels of protection for the elderly. from the U.K., which also indicates two Pfizer shots offer less than 40% protection against infection with omicron.

to data suggesting omicron causes less severe disease, finding adults diagnosed with Covid-19 during South Africa’s fourth and current coronavirus wave were 29% less likely to be admitted to hospital than during the first wave in early 2020. Despite the race to understand the new variant, there is little hard data on omicron.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study FindsPfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »

Pfizer to Push Back Its COVID-19 Vaccine for Babies and ToddlersRead about a statement from Pfizer and BioNTech, in which they explain they will now be testing a three-dose COVID-19 vaccine for the youngest age group of babies and toddlers.
Read more »

CDC recommends opting for Pfizer or Moderna over J&J when there's a choiceCDC recommends opting for Pfizer or Moderna over J&J when there's a choiceThe rare blood clots are not a new safety concern, and the vaccine has already become far less common in the US.
Read more »

CDC Recommends Pfizer, Moderna Covid-19 Vaccines Over J&J’sCDC Recommends Pfizer, Moderna Covid-19 Vaccines Over J&J’sHealth authorities said the rate of a rare but serious blood-clotting disorder associated with the Johnson & Johnson shot is higher than previously detected.
Read more »

In setback, Pfizer tests three doses of COVID vaccine for children under 5In setback, Pfizer tests three doses of COVID vaccine for children under 5Pfizer is testing an extra dose of its COVID-19 vaccine for babies and preschoolers after preliminary research hinted the usual two doses wouldn't be enough.
Read more »

Pfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study FindsPfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study FindsI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »



Render Time: 2025-03-24 11:07:52